Literature DB >> 509873

Choice of control groups in the appraisal of sympathetic nervous activity in essential hypertension.

D H Jones, C A Hamilton, J L Reid.   

Abstract

1. Plasma noradrenaline concentrations were similar in normotensive and hypertensive outpatients, but were significantly lower in laboratory control subjects. 2. Standing plasma noradrenaline concentrations were similar in all three groups. 3. Urinary vanillyl mandelic acid, catecholamines and metanephrines were also similar in the normotensive and hypertensive groups. 4. Laboratory controls, possibly because of familiarity with the techniques of sphygmomanometry and blood sampling, may attain a 'basal' resting level of sympathetic nervous discharge more readily and rapidly than subjects who are unfamiliar with such procedures. 5. After orthostatic stimulation by standing for 2 min, the activity of the sympathetic nervous system, as determined by pulse rate and plasma noradrenaline concentrations, was similar in the three groups, despite the lower starting values in the laboratory staff. 6. The absence of differences in plasma noradrenaline or urinary catecholamine and metabolite concentrations does not support the hypothesis of excessive sympathetic nervous activity in essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 509873     DOI: 10.1042/cs0570339

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  2 in total

1.  Analysis of biogenic amines in plasma of hypertensive patients and a control group.

Authors:  R Andrew; S A Best; D G Watson; J M Midgley; J L Reid; I B Squire
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

2.  Effect of beta-adrenergic receptor blockade with propranolol on the response of plasma catecholamines and renin activity to upright tilting in normal subjects.

Authors:  R Vandongen; L Davidson; L J Beilin; A E Barden
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.